Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · IEX Real-Time Price · USD
2.61
0.09 (3.69%)
At close: May 27, 2022 3:56 PM
2.21
-0.40 (-15.42%)
After-hours:May 27, 2022 7:30 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Selling, General & Admin | 10.78 | 2.4 | 2.42 |
| Research & Development | 2.03 | 2.2 | 3.51 |
| Operating Expenses | 12.81 | 4.6 | 5.93 |
| Operating Income | -12.81 | -4.6 | -5.93 |
| Other Expense / Income | -0.07 | 0 | 0 |
| Pretax Income | -12.75 | -4.6 | -5.93 |
| Net Income | -12.75 | -4.6 | -5.93 |
| Net Income Common | -12.75 | -4.6 | -5.93 |
| Shares Outstanding (Basic) | 9 | 6 | - |
| Shares Outstanding (Diluted) | 9 | 6 | - |
| Shares Change | 37.88% | - | - |
| EPS (Basic) | -1.49 | -0.74 | - |
| EPS (Diluted) | -1.49 | -0.74 | - |
| Free Cash Flow Per Share | -0.59 | -0.54 | - |
| EBITDA | -12.75 | -4.6 | -5.93 |
| EBIT | -12.75 | -4.6 | -5.93 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).